Summary
24.49 -0.27(-1.09%)07/05/2024
DENTSPLY Sirona Inc (XRAY)
DENTSPLY Sirona Inc (XRAY)
Key Facts
| 1 Day | 1 Week | 1 Month | 3 Months | 6 Months | 1 Year | 5 Years | All Time |
| -1.09 | -1.51 | -11.72 | -22.21 | -28.90 | -37.44 | -56.20 | 4,372.17 |
Last 730 data points are shown. To view all data, Upgrade to PRO plan with only $1
| Trading Data | ||
| Close | 24.49 | |
| Open | 24.64 | |
| High | 24.64 | |
| Low | 24.28 | |
| Volume | 839,284 | |
| Change | -0.27 | |
| Change % | -1.09 | |
| Avg Volume (20 Days) | 1,786,764 | |
| Volume/Avg Volume (20 Days) Ratio | 0.47 | |
| 52 Week Range | 24.34 - 41.65 | |
| Price vs 52 Week High | -41.20% | |
| Price vs 52 Week Low | 0.62% | |
| Range | 1.33 | |
| Gap Up/Down | -0.39 | |
Fundamentals | ||
| Market Capitalization (Mln) | 5,141 | |
| EBIDTA | 995,000,000 | |
| PE Ratio | 27.9390 | |
| PEG Ratio | 18.9096 | |
| WallStreet Target Price | 69.42 | |
| Book Value | 23.4310 | |
| Earnings Per Share | 1.9020 | |
| EPS Estimate Current Quarter | 0.6500 | |
| EPS Estimate Next Quarter | 0.8000 | |
| EPS Estimate Current Year | 2.8900 | |
| EPS Estimate Next Year | 3.1900 | |
| Diluted EPS (TTM) | 1.9020 | |
| Revenues | ||
| Profit Marging | 0.0985 | |
| Operating Marging (TTM) | 0.1524 | |
| Return on asset (TTM) | 0.0445 | |
| Return on equity (TTM) | 0.0846 | |
| Revenue TTM | 4,244,999,936 | |
| Revenue per share TTM | 19.4190 | |
| Quarterly Revenue Growth (YOY) | 0.1940 | |
| Quarterly Earnings Growth (YOY) | 0.9380 | |
| Gross Profit (TTM) | 1,701,000,000 | |
| Dividends | ||
| Dividend Share | 0.4200 | |
| Dividend Yield | 0.0079 | |
| Valuations | ||
| Trailing PE | 27.9390 | |
| Forward PE | 16.8350 | |
| Price Sales (TTM) | 0.0000 | |
| Price Book (MRQ) | 2.2744 | |
| Revenue Enterprise Value | 3.1999 | |
| EBITDA Enterprise Value | 14.2835 | |
| Shares | ||
| Shares Outstanding | 218,607,008 | |
| Shares Float | 217,529,293 | |
| Shares Short | 0 | |
| Shares Short (Prior Month) | 0 | |
| Shares Ratio | 0.00 | |
| Short Outstanding (%) | 0.00 | |
| Short Float (%) | 0.00 | |
| Insider (%) | 0.35 | |
| Institutions (%) | 97.68 | |
07/03 11:30 EST - accesswire.com
The Schall Law Firm Invites XRAY Investors To Join The Probe Into Alleged Securities Fraud At DENTSPLY SIRONA Inc
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
The Schall Law Firm Invites XRAY Investors To Join The Probe Into Alleged Securities Fraud At DENTSPLY SIRONA Inc
LOS ANGELES, CA / ACCESSWIRE / July 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
07/02 13:15 EST - accesswire.com
Investors In XRAY Can Participate In The Investigation Of DENTSPLY SIRONA Inc With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
Investors In XRAY Can Participate In The Investigation Of DENTSPLY SIRONA Inc With The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in DENTSPLY SIRONA Inc. ("Dentsply" or "the Company") (NASDAQ:XRAY) for potential breaches of fiduciary duty on the part of its directors and management. The investigation focuses on determining if the Dentsply board breached its fiduciary duties to shareholders.
06/25 13:50 EST - zacks.com
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
Reasons to Retain DENTSPLY SIRONA (XRAY) in Your Portfolio Now
DENTSPLY SIRONA (XRAY) continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.
06/17 10:15 EST - prnewswire.com
NASDAQ: XRAY Lawsuit Update: Investors who lost money with shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) should contact the the Shareholders Foundation
SAN DIEGO , June 17, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY). Investors, who purchased DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares in 2021 or earlier and continue to hold any of those NASDAQ: XRAY shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
NASDAQ: XRAY Lawsuit Update: Investors who lost money with shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) should contact the the Shareholders Foundation
SAN DIEGO , June 17, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in shares of DENTSPLY SIRONA Inc. (NASDAQ: XRAY). Investors, who purchased DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares in 2021 or earlier and continue to hold any of those NASDAQ: XRAY shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
06/13 08:00 EST - prnewswire.com
DENTSPLY SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. (NASDAQ: XRAY) and Encourages Long-Term XRAY Shareholders to Contact the Firm
PHILADELPHIA , June 13, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) ("Dentsply") on behalf of the company's long-term investors. Recently an amended securities fraud complaint was filed against Dentsply on behalf of certain investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022.
DENTSPLY SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Dentsply Sirona Inc. (NASDAQ: XRAY) and Encourages Long-Term XRAY Shareholders to Contact the Firm
PHILADELPHIA , June 13, 2024 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Dentsply Sirona Inc. (NASDAQ: XRAY) ("Dentsply") on behalf of the company's long-term investors. Recently an amended securities fraud complaint was filed against Dentsply on behalf of certain investors who purchased shares of the company's stock between June 9, 2021 and November 13, 2022.
06/12 16:55 EST - globenewswire.com
Dentsply Sirona Provides Update on June Investor Conference Participation
CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions. Prior to this announcement, the Company was scheduled to participate on June 13, 2024, at 8:00 am ET.
Dentsply Sirona Provides Update on June Investor Conference Participation
CHARLOTTE, N.C., June 12, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that it is canceling its participation in the Goldman Sachs 45th Annual Global Healthcare Conference due to weather-related flight disruptions. Prior to this announcement, the Company was scheduled to participate on June 13, 2024, at 8:00 am ET.
06/07 18:25 EST - prnewswire.com
DENTSPLY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
NEW ORLEANS , June 7, 2024 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
DENTSPLY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
NEW ORLEANS , June 7, 2024 /PRNewswire/ -- Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq.
05/30 16:15 EST - globenewswire.com
Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
Dentsply Sirona to Participate in Upcoming Investor Conferences
CHARLOTTE, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its participation at upcoming conferences.
05/29 06:15 EST - prnewswire.com
Investors who lost money with DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares should contact the Shareholders Foundation in connection with Lawsuit
SAN DIEGO , May 29, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in NASDAQ: XRAY shares over alleged securities laws violations by DENTSPLY SIRONA Inc. Investors, who purchased DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares in 2021 or earlier and continue to hold any of those NASDAQ: XRAY shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On June 02, 2022, a lawsuit was filed by an investor in NASDAQ: XRAY shares.
Investors who lost money with DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares should contact the Shareholders Foundation in connection with Lawsuit
SAN DIEGO , May 29, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announced an update in the lawsuit that is pending for certain investors in NASDAQ: XRAY shares over alleged securities laws violations by DENTSPLY SIRONA Inc. Investors, who purchased DENTSPLY SIRONA Inc. (NASDAQ: XRAY) shares in 2021 or earlier and continue to hold any of those NASDAQ: XRAY shares, have also certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. On June 02, 2022, a lawsuit was filed by an investor in NASDAQ: XRAY shares.
05/22 16:10 EST - globenewswire.com
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 12, 2024, to holders of record as of June 28, 2024.
Dentsply Sirona Declares Quarterly Cash Dividend
CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of common stock, an indicated annual rate of $0.64 per share. The dividend is payable on July 12, 2024, to holders of record as of June 28, 2024.
05/22 06:15 EST - investorplace.com
7 Long-Term Stocks to Buy Now: May 2024
On a day-to-day basis, the stock market can do almost anything. Short-term returns tend to be highly volatile and quite random in nature.
7 Long-Term Stocks to Buy Now: May 2024
On a day-to-day basis, the stock market can do almost anything. Short-term returns tend to be highly volatile and quite random in nature.
05/10 17:06 EST - businesswire.com
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY). On April 19, 2022, the Company disclosed the sudden termination of CEO Donald Casey “effective immediately.” Then, on May 10, 2022, the Company disclosed an ongoing investigation by its Audit and Finance Committee, outside counsel and a forensic.
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Dentsply Sirona, Inc. (NasdaqGS: XRAY). On April 19, 2022, the Company disclosed the sudden termination of CEO Donald Casey “effective immediately.” Then, on May 10, 2022, the Company disclosed an ongoing investigation by its Audit and Finance Committee, outside counsel and a forensic.
05/06 10:26 EST - zacks.com
Understanding Dentsply (XRAY) Reliance on International Revenue
Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
Understanding Dentsply (XRAY) Reliance on International Revenue
Evaluate Dentsply's (XRAY) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.
05/02 21:48 EST - seekingalpha.com
DENTSPLY SIRONA Inc. (XRAY) Q1 2024 Earnings Call Transcript
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2024 Results Conference Call May 2, 2024 8:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - CEO, President & Director Glenn Coleman - Chief Financial Officer Andreas Frank - Executive Vice President & Chief Business Officer Conference Call Participants David Saxon - Needham & Company Jeff Johnson - Baird Dylan Finley - UBS Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler Jordan Bernstein - Stifel Sarah Conrad - Goldman Sachs Justin Lin - William Blair Allen Lutz - Bank of America Michael Petusky - Barrington Research Erin Wright - Morgan Stanley Operator Good day, everyone. And thank you for standing by.
DENTSPLY SIRONA Inc. (XRAY) Q1 2024 Earnings Call Transcript
DENTSPLY SIRONA Inc. (NASDAQ:XRAY ) Q1 2024 Results Conference Call May 2, 2024 8:30 AM ET Company Participants Andrea Daley - Vice President-Investor Relations Simon Campion - CEO, President & Director Glenn Coleman - Chief Financial Officer Andreas Frank - Executive Vice President & Chief Business Officer Conference Call Participants David Saxon - Needham & Company Jeff Johnson - Baird Dylan Finley - UBS Elizabeth Anderson - Evercore ISI Jason Bednar - Piper Sandler Jordan Bernstein - Stifel Sarah Conrad - Goldman Sachs Justin Lin - William Blair Allen Lutz - Bank of America Michael Petusky - Barrington Research Erin Wright - Morgan Stanley Operator Good day, everyone. And thank you for standing by.
05/02 14:06 EST - zacks.com
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
DENTSPLY SIRONA (XRAY) Q1 Earnings In Line, Revenues Decline Y/Y
DENTSPLY SIRONA's (XRAY) first-quarter 2024 results showcase a decline in year-over-year sales with an improved bottom line.
05/02 12:31 EST - zacks.com
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Here's What Key Metrics Tell Us About Dentsply (XRAY) Q1 Earnings
While the top- and bottom-line numbers for Dentsply (XRAY) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
05/02 08:11 EST - zacks.com
Dentsply International (XRAY) Meets Q1 Earnings Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.39 per share a year ago.
Dentsply International (XRAY) Meets Q1 Earnings Estimates
Dentsply International (XRAY) came out with quarterly earnings of $0.42 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.39 per share a year ago.
05/02 06:00 EST - globenewswire.com
Dentsply Sirona Reports First Quarter 2024 Results
CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2024.
Dentsply Sirona Reports First Quarter 2024 Results
CHARLOTTE, N.C, May 02, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced its financial results for the first quarter of 2024.